| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0006 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
| mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
| mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |